Evidence map›Paper›PMID 39315804›Full record

ArticleAntimicrobial agents and chemotherapy2024

Molecular insights into the evolutionary trajectory of a

Youssouf Sereme, Hélène Faury, Victor Gravrand, Elisabeth Ageron, Claire Poyart, David Skurnik, Hedi Mammeri

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Youssouf SeremeCNRS, INSERM, Institut Necker Enfants Malades, Université Paris Cité, Paris, France.
Hélène FauryCNRS, INSERM, Institut Necker Enfants Malades, Université Paris Cité, Paris, France.
Victor GravrandService de Bactériologie, Hôpitaux Universitaires Paris Centre, Site Cochin, Assistance Publique Hôpitaux de Paris, Paris, France.
Elisabeth AgeronCNRS, INSERM, Institut Necker Enfants Malades, Université Paris Cité, Paris, France.
Claire PoyartService de Bactériologie, Hôpitaux Universitaires Paris Centre, Site Cochin, Assistance Publique Hôpitaux de Paris, Paris, France.
David Skurnik *CNRS, INSERM, Institut Necker Enfants Malades, Université Paris Cité, Paris, France.ORCID 0000-0002-4205-9639
Hedi Mammeri *CNRS, INSERM, Institut Necker Enfants Malades, Université Paris Cité, Paris, France.ORCID 0000-0001-8022-5792

Funding

Agence Nationale de la Recherche (ANR) ESAAM
6 · The paper itself

Abstract

The fitness cost associated with antimicrobial resistance has an important influence on evolutionary dynamics. We compared the genomes of three

Indexed as

Anti-Bacterial Agentsbeta-LactamasesMicrobial Sensitivity TestsAnimalsDrug Resistance, Multiple, BacterialEnterobacter aerogenesHumansKlebsiella InfectionsMicePiperacillin, Tazobactam Drug CombinationVirulenceWhole Genome SequencingAnti-Bacterial Agentsbeta-Lactamasesbeta-lactamase TEM-1Piperacillin, Tazobactam Drug CombinationcefepimeESBLfitnessOmpK36overproductionporinresistanceTEMvirulence

Identifiers

PMID39315804
PMCPMC11539205

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.